The big stem cell news already this week is the acquisition by Fujifilm of Cellular Dynamics International (CDI) for a whopping $307 million dollars or about $16.50 per CDI share. You can read the press release here. Update: The entity is now known as Fujifilm Cellular Dynamics. It was less than two years ago that CDI did […]
Was Fujifilm CDI acquisition a good move by the companies? Read More »
Here are some papers and news for weekend reads. What are you reading this weekend? What are your go-to stem cell journals? Hostile Takeover: Glioma Stem Cells Recruit TAMs to Support Tumor Progression by Yu Shi, Yi-fang Ping, Xia Zhang, Xiu-wu Bian in Cell Stem Cell. YAP1 Regulates OCT4 Activity and SOX2 Expression to Facilitate self-renewal and
Weekend Reads: Cool Papers, PubPeer, Jacob Hanna, & More Read More »
It’s been exciting to watch the recent developments in using stem cells as the basis for treatments for Type I Diabetes. One of the major players in this arena is the privately-held company, ViaCyte. In this post, I interview ViaCyte President and CEO, Paul Laikind. The topics include their VC-01 product, the Encaptra device, an update on
ViaCyte CEO Laikind Interview: Trial Update, Melton, & Future Read More »
The science reads on my radar screen to read in my ample spare time as I work the weekend on literally 5 different grants include these pieces: NECSS and SfSBM: A weekend of science and skepticism Breaking Down Fat: Trends in adipose cell-based clinical trials PubPeer Selections: Odd citations, “practice makes perfect,” a Nature update
Recommended Weekend Science Reads Read More »
One of my goals is promoting evidence-based medicine and science-based medicine that is in the best interest of the community including patients. Below is a list of recommended reading for you including mostly blogs, but also other resources that should be on your regular must-read list. Some are stem cell-focused, while most are broader. California
Recommended reading for innovative, evidence-based medicine Read More »
A lot has happened in 2014 in the stem cell and regenerative medicine field and so much of it has been good news so let’s focus on the positive. These positive developments are often the result of many years of creative, hard work by amazing teams of researchers. Here is my top 10 list of
Positive Stem Cell Developments in 2014 Read More »
Every year I look into my stem cell crystal ball and make a top 10 list of stem cell predictions for the coming year. My predictions for 2015 will be coming up soon and I may bump them up to 20 predictions instead of 10 because there’s so much going on in the field. Stay
Stem cell crystal ball: how did my 2014 predictions fare? Read More »
What does this stem cell blog focus on? Even I am not always sure of patterns unless I analyze my own posts.Inspired by DrugMonkeyBlog, I have gone through and listed the first ipscell.com blog posts of each of the 12 months of 2014. It makes for a surprising summary of the year. Think of it as
The 12 months of stem cell blog mass Read More »
Recently I was at the World Alliance Forum in San Francisco (WAFSF), a great meeting on stem cells and regenerative medicine. WAFSF had some excellent talks and I saw one session on the use of stem cells to treat vision impairment that was particularly striking. World Alliance Forum in San Francisco (WAFSF) This session’s all-star lineup included Drs. David
WAFSF stem cell vision talks: Hinton, Tsukamoto, Klassen, Takahashi Read More »
What are super cells? Guest post by Lisa Willemse Last month, on this blog, Paul wrote an article about loopholes in the clinicaltrials.gov database that allows for-profit companies to advertise their “therapies” under the guise of a registered clinical trial. This is a real concern for our community, especially those among us who have recommended
Super Cells exhibit and why we bother with public outreach Read More »